T. Rowe Price Associates’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-19,576
| Closed | -$560K | – | 2575 |
|
|
2018
Q4 | $560K | Buy |
19,576
+108
| +0.6% | +$3.09K | ﹤0.01% | 2026 |
|
|
2018
Q3 | $543K | Sell |
19,468
-121
| -0.6% | -$3.38K | ﹤0.01% | 2118 |
|
|
2018
Q2 | $547K | Buy |
19,589
+5,397
| +38% | +$151K | ﹤0.01% | 2089 |
|
|
2018
Q1 | $353K | Buy |
14,192
+127
| +0.9% | +$3.16K | ﹤0.01% | 2210 |
|
|
2017
Q4 | $341K | Buy |
14,065
+5,780
| +70% | +$140K | ﹤0.01% | 2219 |
|
|
2017
Q3 | $229K | Hold |
8,285
| – | – | ﹤0.01% | 2351 |
|
|
2017
Q2 | $208K | Buy |
8,285
+10
| +0.1% | +$251 | ﹤0.01% | 2367 |
|
|
2017
Q1 | $222K | Hold |
8,275
| – | – | ﹤0.01% | 2362 |
|
|
2016
Q4 | $217K | Sell |
8,275
-25
| -0.3% | -$656 | ﹤0.01% | 2360 |
|
|
2016
Q3 | $207K | Buy |
+8,300
| New | +$207K | ﹤0.01% | 2344 |
|